Annual Total Debt
$14.44 M
+$1.18 M+8.88%
31 December 2023
Summary:
Keros Therapeutics annual total debt is currently $14.44 million, with the most recent change of +$1.18 million (+8.88%) on 31 December 2023. During the last 3 years, it has risen by +$13.54 million (+1506.67%). KROS annual total debt is now at all-time high.KROS Total Debt Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Total Debt
$19.29 M
+$5.33 M+38.18%
30 September 2024
Summary:
Keros Therapeutics quarterly total debt is currently $19.29 million, with the most recent change of +$5.33 million (+38.18%) on 30 September 2024. Over the past year, it has increased by +$4.97 million (+34.73%). KROS quarterly total debt is now at all-time high.KROS Quarterly Total Debt Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
KROS Total Debt Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +8.9% | +34.7% |
| 3 y3 years | +1506.7% | +1388.1% |
| 5 y5 years | +1733.0% | +100.0% |
KROS Total Debt High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3 years | at high | +1506.7% | at high | +4138.7% |
| 5 y | 5 years | at high | +1733.0% | at high | |
| alltime | all time | at high | +1733.0% | at high |
Keros Therapeutics Total Debt History
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2024 | - | $19.29 M(+38.2%) |
| June 2024 | - | $13.96 M(-1.7%) |
| Mar 2024 | - | $14.20 M(-1.7%) |
| Dec 2023 | $14.44 M(+8.9%) | $14.44 M(+0.9%) |
| Sept 2023 | - | $14.31 M(+2.6%) |
| June 2023 | - | $13.95 M(-0.3%) |
| Mar 2023 | - | $13.99 M(+5.5%) |
| Dec 2022 | $13.27 M(+1113.7%) | $13.27 M(+2815.6%) |
| Sept 2022 | - | $455.00 K(-32.1%) |
| June 2022 | - | $670.00 K(-24.2%) |
| Mar 2022 | - | $884.00 K(-19.1%) |
| Dec 2021 | $1.09 M | $1.09 M(-15.7%) |
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2021 | - | $1.30 M(+87.6%) |
| June 2021 | - | $691.00 K(-13.3%) |
| Mar 2021 | - | $797.00 K(-11.3%) |
| Dec 2020 | $899.00 K(-29.5%) | $899.00 K(-9.9%) |
| Sept 2020 | - | $998.00 K(-8.6%) |
| June 2020 | - | $1.09 M(-7.8%) |
| Mar 2020 | - | $1.19 M(-7.1%) |
| Dec 2019 | $1.27 M(+61.8%) | $1.27 M(>+9900.0%) |
| Sept 2019 | - | $0.00(0.0%) |
| June 2019 | - | $0.00(0.0%) |
| Mar 2019 | - | $0.00 |
| Dec 2018 | $788.00 K | - |
FAQ
- What is Keros Therapeutics annual total debt?
- What is the all time high annual total debt for Keros Therapeutics?
- What is Keros Therapeutics annual total debt year-on-year change?
- What is Keros Therapeutics quarterly total debt?
- What is the all time high quarterly total debt for Keros Therapeutics?
- What is Keros Therapeutics quarterly total debt year-on-year change?
What is Keros Therapeutics annual total debt?
The current annual total debt of KROS is $14.44 M
What is the all time high annual total debt for Keros Therapeutics?
Keros Therapeutics all-time high annual total debt is $14.44 M
What is Keros Therapeutics annual total debt year-on-year change?
Over the past year, KROS annual total debt has changed by +$1.18 M (+8.88%)
What is Keros Therapeutics quarterly total debt?
The current quarterly total debt of KROS is $19.29 M
What is the all time high quarterly total debt for Keros Therapeutics?
Keros Therapeutics all-time high quarterly total debt is $19.29 M
What is Keros Therapeutics quarterly total debt year-on-year change?
Over the past year, KROS quarterly total debt has changed by +$4.97 M (+34.73%)